Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
User-agent: * Sitemap: https://www.imfinzihcp.com/sitemap.xml Disallow: /404.html Disallow: /404 Disallow: /500.html Disallow: /500 Disallow: /thank-you Disallow: /thank-you.html Disallow: /exit-ramp.html Disallow: /exit-ramp Disallow: /content-area/ Disallow: /swf Disallow: /etc/tags Disallow: /content/campaigns Disallow: |
Title | Immunotherapy for Unresectable HCC, Advanced BTC, Stage III or IV NSCLC, & ES-SCLC | For HCPs | |
Description | REACH FOR MORE POSSIBILITIES WITH IMFINZI ALONE OR IN COMBINATION WITH Learn more about IMFINZI® (durvalumab), an immunotherapy for adult patients with metastatic NSCLC, unresectable Stage III NSCLC, extensive-stage SCLC, advanced or metastatic BTC, & unresectable |
Keywords | N/A |
WebSite | imfinzihcp.com |
Host IP | 13.249.137.26 |
Location | United States |
Site | Rank |
US$14,138,400
Last updated: 2023-05-08 10:25:05
imfinzihcp.com has Semrush global rank of 748,621. imfinzihcp.com has an estimated worth of US$ 14,138,400, based on its estimated Ads revenue. imfinzihcp.com receives approximately 1,631,354 unique visitors each day. Its web server is located in United States, with IP address 13.249.137.26. According to SiteAdvisor, imfinzihcp.com is safe to visit. |
Purchase/Sale Value | US$14,138,400 |
Daily Ads Revenue | US$13,051 |
Monthly Ads Revenue | US$391,525 |
Yearly Ads Revenue | US$4,698,300 |
Daily Unique Visitors | 108,757 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
imfinzihcp.com. | A | 299 | IP: 13.249.137.26 |
imfinzihcp.com. | A | 299 | IP: 13.249.137.65 |
imfinzihcp.com. | A | 299 | IP: 13.249.137.5 |
imfinzihcp.com. | A | 299 | IP: 13.249.137.7 |
imfinzihcp.com. | NS | 86400 | NS Record: ns-1775.awsdns-29.co.uk. |
imfinzihcp.com. | NS | 86400 | NS Record: ns-979.awsdns-58.net. |
imfinzihcp.com. | NS | 86400 | NS Record: ns-1229.awsdns-25.org. |
imfinzihcp.com. | NS | 86400 | NS Record: ns-154.awsdns-19.com. |
FOR US HEALTHCARE PROFESSIONALS FOR PATIENTS & CAREGIVERS» Important Safety Information Prescribing Information IMFINZI Prescribing Information IMJUDO Prescribing Information Medical Resources Important Safety Information MENU + Select an Indication Unresectable Stage III Non-small Cell Lung Cancer Home IMFINZI After CRT The PACIFIC Regimen Activate Immune Response Efficacy Overall Survival Progression-free Survival Clinical Guidelines Consider IMFINZI Study Design Post-hoc Analysis Post-hoc Analysis Baseline Characteristics Safety Adverse Reactions Discontinuation Rate Immune-mediated Adverse Reactions Laboratory Abnormalities Dosing Recommended Dosage Dosage Modifications Preparation, Storage, and Administration Extensive-stage Small Cell Lung Cancer Home Efficacy Overall Survival Progression-free Survival ORR and DoR Study Design and Patient Characteristics Patient-reported Outcomes Global Health Status/QoL and Functioning Scales Symptom Scales Safety Adverse Reactions |
HTTP/1.1 403 Forbidden Server: CloudFront Date: Fri, 29 Oct 2021 20:48:23 GMT Content-Type: text/html Content-Length: 919 Connection: keep-alive X-Cache: Error from cloudfront Via: 1.1 5da5773a6acab8f3aabf385b38683f20.cloudfront.net (CloudFront) X-Amz-Cf-Pop: ORD51-C1 X-Amz-Cf-Id: tCz7crKuIJo8jpBRiTjWm7fjKvORbZcZfpxusn5_bfNWhIvLH-wEcw== |
Domain Name: IMFINZIHCP.COM Registry Domain ID: 2044918074_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.corporatedomains.com Registrar URL: http://cscdbs.com Updated Date: 2021-07-17T05:08:38Z Creation Date: 2016-07-21T14:45:56Z Registry Expiry Date: 2022-07-21T14:45:56Z Registrar: CSC Corporate Domains, Inc. Registrar IANA ID: 299 Registrar Abuse Contact Email: domainabuse@cscglobal.com Registrar Abuse Contact Phone: 8887802723 Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Name Server: NS-1229.AWSDNS-25.ORG Name Server: NS-154.AWSDNS-19.COM Name Server: NS-1775.AWSDNS-29.CO.UK Name Server: NS-979.AWSDNS-58.NET DNSSEC: unsigned >>> Last update of whois database: 2021-09-17T08:59:20Z <<< |